Related Experiment Video
Updated: May 21, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Infantile dilated cardiomyopathy caused by RPL3L gene mutation: A case report
Biwei Mai1, Zhixian Lei1, Shanqing Qin1
1Pediatric Intensive Care Unit, Hainan Women and Children's Medical Center, China.
Insights
Mutations in the ribosomal protein L3-like gene (RPL3L) can cause severe early-onset dilated cardiomyopathy. This case highlights familial RPL3L gene mutations in an infant, leading to successful treatment and recovery.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a serious heart condition.
- Mutations in the ribosomal protein L3-like gene (RPL3L) are linked to early-onset DCM.
Purpose of the Study:
- To report a case of DCM in an infant due to RPL3L gene mutations.
- To investigate the genetic basis and inheritance pattern of DCM in this family.
Main Methods:
- Clinical assessment including echocardiography, chest X-ray, and cardiac MRI.
- Whole-exome sequencing to identify genetic mutations.
- Monitoring of cardiac function during drug therapy.
Main Results:
- An infant presented with severe DCM, poor appetite, breathlessness, and lethargy.
- Whole-exome sequencing revealed two RPL3L mutations (c.501G>A and c.322G>A), inherited from both parents.
- The patient showed improved cardiac function with drug therapy, normalizing within 6 months.
Conclusions:
- Familial RPL3L gene mutations are associated with early-onset dilated cardiomyopathy.
- The findings support an autosomal recessive inheritance pattern for RPL3L-associated cardiomyopathy.
- Early diagnosis and treatment can lead to favorable outcomes in affected infants.
Abstract:
Ribosomal protein L3-like gene mutations have been implicated in early-onset severe dilated cardiomyopathy (OMIM #115200). This report describes an infant with dilated cardiomyopathy resulting from RPL3L gene mutations. A 2-month-old girl was admitted in June 2022 with poor appetite, breathlessness, and lethargy. Her brother had succumbed to fulminant cardiomyopathy and heart failure at the same age. Cardiac ultrasound revealed an enlarged left ventricle, moderate mitral valve regurgitation, and an ejection fraction of 31%. Chest X-ray revealed cardiac enlargement and pulmonary changes. Cardiac magnetic resonance imaging confirmed dilated cardiomyopathy with an enlarged left ventricle and reduced myocardial wall motion. Whole-exome sequencing identified two RPL3L mutations: c.501G>A (p.Q167=) inherited from the father and c.322G>A (p.E108K) from the mother. Drug therapy improved the patient's cardiac function, and she demonstrated normal cardiac function after 6 months. In this case, dilated cardiomyopathy was associated with two familial RPL3L gene mutations, consistent with a presumed autosomal recessive inheritance pattern previously described in RPL3L-associated cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease I: Introduction
Animal Mitochondrial Genetics

